Canandaigua National Bank & Trust CO Gilead Sciences, Inc. Transaction History

Canandaigua National Bank & Trust CO

$979 Million
Q1 2025

A detailed history of Canandaigua National Bank & Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 5,972 shares of GILD stock, worth $641,213. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,972

Previous 5,912 1.01%

Holding current value

$641,213

Previous $546,000 22.53%

% of portfolio

0.07%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$89.14 - $117.41 $5,348 - $7,044	60 Added 1.01%	5,972 $669,000
Q4 2024 Jan 06, 2025	SELL	$83.95 - $97.9 $6,967 - $8,125	-83 Reduced 1.38%	5,912 $546,000
Q3 2024 Oct 03, 2024	SELL	$66.59 - $83.99 $12,252 - $15,454	-184 Reduced 2.98%	5,995 $502,000
Q2 2024 Jul 11, 2024	SELL	$63.15 - $72.88 $195,765 - $225,928	-3,100 Reduced 33.41%	6,179 $423,000
Q1 2024 Apr 01, 2024	BUY	$71.58 - $87.29 $3,077 - $3,753	43 Added 0.47%	9,279 $679,000
Q4 2023 Jan 04, 2024	SELL	$73.27 - $83.09 $3,663 - $4,154	-50 Reduced 0.54%	9,236 $748,000
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $11,091 - $12,100	-150 Reduced 1.59%	9,286 $695,000
Q2 2023 Jul 03, 2023	BUY	$76.01 - $86.7 $3,876 - $4,421	51 Added 0.54%	9,436 $727,000
Q1 2023 Apr 11, 2023	SELL	$77.31 - $88.08 $232,007 - $264,328	-3,001 Reduced 24.23%	9,385 $779,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $114,487 - $146,642	-1,828 Reduced 12.86%	12,386 $926,000
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $145,238 - $159,757	-2,357 Reduced 14.22%	14,214 $924,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $177,653 - $196,098	2,842 Added 20.7%	16,571 $1.05 Million
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $15,220 - $17,067	-246 Reduced 1.76%	13,729 $928,000
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $209,287 - $234,457	-3,347 Reduced 19.32%	13,975 $909,000
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $83,000 - $108,309	-1,371 Reduced 7.33%	17,322 $1.08 Million
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $10,692 - $11,838	-150 Reduced 0.8%	18,693 $1.44 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $222,733 - $259,809	-3,433 Reduced 15.41%	18,843 $1.34 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $1.62 Million - $1.98 Million	22,276 New	22,276 $1.68 Million

Others Institutions Holding GILD

# of Institutions

2,285

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $135B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.

Account

Canandaigua National Bank & Trust CO Gilead Sciences, Inc. Transaction History